September 2, 2020
Taisho Pharmaceutical has agreed to end a distribution deal with Takeda Pharmaceutical for prescription drugs manufactured by its subsidiary Biofermin Pharmaceutical in Japan by the end of December 2020, its parent Taisho Holdings said on August 31. Taisho will be...read more